Terms and Conditions
Welcome to the EyePoint Corp. website. The information provided on this site is for general informational and educational purposes only. Please read and review these Terms and Conditions carefully before accessing or using this website.
General Use of Site
Use of the EyePoint corporate website (the Site) is subject to the following terms and conditions, which may be changed by EyePoint from time to time. Users are responsible for regularly reviewing these terms and conditions. Continued use of this Site following any such changes shall constitute an acceptance of the new terms and conditions.
PLEASE READ THESE TERMS CAREFULLY AS USE OF THIS SITE CONSTITUTES AGREEMENT TO THESE TERMS AND CONDITIONS.
Trademark and Copyright
All product names, whether or not appearing in large print or with the trademark symbol, are trademarks of EyePoint, its affiliates, related companies, or its licensors or partners, unless otherwise noted. The use or misuse of these trademarks or any other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trademark law, the laws of slander and libel, the laws of privacy and publicity, and communications regulations and statutes. Please be advised that EyePoint actively and aggressively enforces its intellectual property rights to the fullest extent of the law. The entire contents of this Site are subject to copyright protection. The contents of this Site may not be copied other than for non-commercial individual reference with all copyright or other proprietary notices retained, and thereafter may not be recopied, reproduced or otherwise redistributed. Except as expressly provided above, you may not otherwise copy, display, download, distribute, modify, reproduce, republish, or retransmit any information, text, or documents contained in this Site or any portion thereof in any electronic medium or in hard copy, or create any derivative work based on such images, text, or documents, without the express written consent of EyePoint. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any copyright, patent, trademark, or other intellectual property right of EyePoint or any third party.
Links to Other Sites and Services
This Site contains links to other websites that are not owned or operated by us. We do not warrant, represent, or assume any responsibility or liability for the operation or security of any such third-party sites, or for the accuracy or completeness of the information, software, or other materials on such sites or any other sites for which links are provided in such linked sites. Links to third-party sites on this Site are not referrals or endorsements by us of such linked sites. We recommend that you familiarize yourself with the notices and legal and other terms and conditions of such third-party linked sites.
You agree to indemnify, defend, and hold harmless EyePoint, its officers, directors, employees, and agents from and against all losses, expenses, damages, and costs, including reasonable attorneys’ fees, resulting from any violation by you of these Terms and Conditions.
This Site may contain general information relating to various medical conditions and their treatment. Such information is provided for informational purposes only and is not meant to be a substitute for advice provided by a doctor or other qualified healthcare professional. Patients should not use the information contained herein for diagnosing a health problem or disease. Patients should always consult with a doctor or other healthcare professional for medical advice or information about diagnosis and treatment. Non-Confidential Information. Any communication or other material that you send to us through the Internet or post on the Site by electronic mail or otherwise, such as any questions, comments, suggestions or the like, is and will be deemed to be non-confidential, and EyePoint shall have no obligation of any kind with respect to such information.
SAFE HARBOR STATEMENTS UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995: Various statements made on this Site are forward-looking, and are inherently subject to risks, uncertainties, and potentially inaccurate assumptions. All statements that address activities, events, or developments that we intend, expect, or believe may occur in the future are forward-looking statements. The following are some of the factors that could cause actual results to differ materially from the anticipated results or other expectations expressed, anticipated, or implied in our forward-looking statements: uncertainties with respect to: Alimera’s ability to finance, achieve additional marketing approvals, successfully commercialize, and achieve market acceptance of, and generate revenues to EyePoint from, ILUVIEN for DME in the EU; Alimera’s resubmission of its NDA for ILUVIEN for DME and its ability to obtain regulatory approval for, and if approved, to finance, successfully commercialize, and achieve market acceptance of, and generate revenues to EyePoint from, ILUVIEN for DME in the U.S.; financing and success of Phase III posterior uveitis trials including efficacy, side effects, and risk/benefit profile of the posterior uveitis micro-insert; initiation, financing, and success of Latanoprost Product Phase II trials and exercise by Pfizer of its option; development of products using Tethadur and BioSilicon; initiation and completion of clinical trials and obtaining regulatory approval of product candidates; adverse side effects; ability to attain profitability; ability to obtain additional capital; further impairment of intangible assets; fluctuations in operating results; decline in royalty revenues; ability to, and to find partners to, develop and market products; termination of license agreements; competition and other developments affecting sales of products; market acceptance; protection of intellectual property and avoiding intellectual property infringement; retention of key personnel; product liability; consolidation in the pharmaceutical and biotechnology industries; compliance with environmental laws; manufacturing risks; risks and costs of international business operations; credit and financial market conditions; legislative or regulatory changes; volatility of stock price; possible dilution; possible influence by Pfizer; absence of dividends; and other factors described in our filings with the SEC. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Our forward-looking statements speak only as of the dates on which they are made. We do not undertake any obligation to publicly update or revise our forward-looking statements even if experience or future changes makes it clear that any projected results expressed or implied in such statements will not be realized.
Security and Compliance with Laws
Users may only use this Site for lawful purposes, and only in their own name. Any violation or attempted violation of the security of this Site, or interference or attempted interference with the proper operation of this Site is expressly forbidden.
THE CONTENTS OF THIS SITE ARE PROVIDED “AS IS” AND WITHOUT ANY WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, TO THE FULLEST EXTENT PERMITTED PURSUANT TO APPLICABLE LAWS. IN ADDITION, WE DO NOT WARRANT THAT YOUR USE OF, OR THE OPERATION OR FUNCTION OF, THIS SITE OR ANY LINKED SITE, ANY COMPONENT THEREOF, OR ANY SERVICES OFFERED IN CONNECTION THEREWITH, WILL BE UNINTERRUPTED OR ERROR FREE; THAT ANY DEFECTS OR ERRORS WILL BE CORRECTED; OR THAT THIS SITE OR ANY LINKED SITE OR ITS SERVERS ARE FREE OF VIRUSES OR OTHER HARMFUL ELEMENTS. IN ADDITION, CERTAIN INFORMATION (INCLUDING STOCK QUOTES) IS PROVIDED BY OR UPDATED FROM SOURCES OTHER THAN US AND EXCEPT AS OTHERWISE PROVIDED UNDER APPLICABLE LAW, WE DO NOT ASSUME ANY LIABILITY OR RESPONSIBILITY FOR THE ACCURACY OF SUCH INFORMATION. WE ARE NOT LIABLE FOR ANY DAMAGES WHATSOEVER, INCLUDING DIRECT, SPECIAL, INDIRECT, CONSEQUENTIAL, OR PUNITIVE DAMAGES, OR FOR DAMAGES FOR LOST PROFITS OR BUSINESS INTERRUPTION, RESULTING FROM ANY USE OF OR RELIANCE ON, THE MATERIALS PROVIDED IN THIS SITE OR ANY LINKED SITE, EVEN IF WE ARE NOTIFIED IN ADVANCE OF THE POTENTIAL FOR ANY SUCH DAMAGES.
We reserve the right to correct any errors, omissions, and any other inaccuracies, and to update or change information at any time without prior notice. This Site is operated by EyePoint from its offices in Watertown, Massachusetts, and these terms and conditions are governed by and shall be construed in accordance with the laws of the Commonwealth of Massachusetts, without regard to any conflict of law provisions.